Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
格式: Artigo
語言:Russo
出版: «FIRMA «SILICEA» LLC 2004-12-01
叢編:Российский кардиологический журнал
主題:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
在線閱讀:https://russjcardiol.elpub.ru/jour/article/view/2326
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍